Press Releases RepliCel Life Sciences Inc. Toronto S.E.

Equities

RP

CA76027P4006

Delayed Toronto S.E. Other stock markets 11:00:00 2024-04-16 EDT			5-day change	1st Jan Change
0.055 ^CAD	-.--%		-21.43%	-15.38%

05-31	RepliCel Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-17	RepliCel Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canadian Investment Regulatory Organization Trading Halt - RP	05-08	AQ
RepliCel Life Sciences : Announces Secured Loan Agreement	04-18	PU
RepliCel Life Sciences : announces a Letter of Intent for Asset Purchase Agreement - Form 6-K	03-20	PU
RepliCel Life Sciences : Letter of Intention (Asset Purchase)	03-18	PU
Canadian Investment Regulatory Organization Trading Halt - RP	03-15	AQ
REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K	11-30	PU
RepliCel Life Sciences : Arbitration decision	11-16	PU
REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K	23-10-24	PU
RepliCel Life Sciences : AGM 2023 Zoom Link and Materials	23-09-21	PU
RepliCel Life Sciences : Notice of Meeting and Record Date - Form 6-K	23-08-17	PU
REPLICEL LIFE SCIENCES : STATEMENT OF EXECUTIVE COMPENSATION - Form 6-K	23-08-10	PU
RepliCel Life Sciences : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K	23-05-31	PU
RepliCel Life Sciences : Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options - Form 6-K	23-05-18	PU
RepliCel Life Sciences : 51-102F3 MATERIAL CHANGE REPORT - Form 6-K	23-03-21	PU
RepliCel Life Sciences : Announces Intention to Pay Dividend on Preferred Shares - Form 6-K	23-02-23	PU
RepliCel Life Sciences : Announces Settlement of Payment of Dividend on Preferred Shares - Form 6-K	23-02-23	PU
RepliCel Life Sciences : NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS - Form 6-K	23-02-02	PU
RepliCel Life Sciences : Change of Auditor Notice - Form 6-K	22-12-09	PU
RepliCel Life Sciences : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K	22-11-30	PU
RepliCel Provides Corporate Update	22-11-29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases RepliCel Life Sciences Inc. Toronto S.E.

Equities

RP

CA76027P4006

Press Releases

Filters